NCT02034292View on ClinicalTrials.gov

Safety Study of APD-791 With Aspirin and/or Clopidogrel

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Clopidogrel

DRUG

Aspirin

DRUG

APD791

DRUG

Placebo

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02034292 - Safety Study of APD-791 With Aspirin and/or Clopidogrel | Biotech Hunter | Biotech Hunter